Closing Bell: Medicenna Therapeutics Corp flat on Wednesday (MDNA)

Today in trading, Medicenna Therapeutics Corp shares opened at $1.93 and closed at $1.95. It traded at a low of $1.90 to a high of $1.97.

Shares $verbed percentage_change% from the previous day's close of $1.95.

Today across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.

Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).

A total of 33,283 shares was traded during the session, with total trades of 65, with an average volume of 42,325 over the last 5 days.

The TSX market on the whole today saw 1,249 price advancers against 3,959 declines and 110 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 275.00% in the last 12 months, while this year, they have risen 364.29%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $145.82 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp's average recommendation is "Strong Buy" based on 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..